Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.64 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.64 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | SCN1A | P35498 | 1/20 | 0.51 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.51 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL166927 | 1.00 | FOLH1 (0.66) | FOLH1ALDH1A1ADRB2HTTMAPT | |
| Hydrochloric Acid SCHEMBL7699238 | 0.98 | FOLH1 (0.63) | FOLH1ALDH1A1ADRB2HTTMAPT | |
| SCHEMBL8702953 | 0.98 | FOLH1 (0.63) | FOLH1ALDH1A1ADRB2HTTMAPT | |
| SCHEMBL8698803 | 0.93 | FOLH1 (0.58) | FOLH1ALDH1A1ADRB2HTTMAPT | |
| SCHEMBL30365583 | 0.91 | FOLH1 (0.76) | FOLH1ALDH1A1ADRB2HTTMAPT | |
| SCHEMBL70392 | 0.91 | FOLH1 (0.76) | FOLH1ALDH1A1ADRB2HTTMAPT | |
| SCHEMBL7764255 | 0.89 | TSHR (0.72) | FOLH1ALDH1A1ADRB2HTTMAPT | |
| SCHEMBL11710027 | 0.88 | FOLH1 (0.61) | FOLH1ALDH1A1ADRB2MAPTTSHR | |
| SCHEMBL20162476 | 0.88 | FOLH1 (0.61) | FOLH1ALDH1A1ADRB2MAPTTSHR | |
| Hydrochloric Acid SCHEMBL8327538 | 0.88 | KMT2A (0.56) | FOLH1ALDH1A1ADRB2HTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4692092-A1 | NOVEL COMPOUNDS WITH MTORC2-INHIBITORY ACTIVITY AND USES THEREOF | Aliad Biopharma (KR) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024205377-A1 | NOVEL COMPOUNDS WITH MTORC2-INHIBITORY ACTIVITY AND USES THEREOF | 알리아드바이오파마 주식회사 | 2024-10-03 | — | — | WO | disclosed |
| US-20230095374-A1 | MEROTERPENOID COMPOUNDS FOR USE IN THE PREVENTION AND TREATMENT OF A NEUROLOGICAL DISORDER | GLIAPHARM SA (CH) | 2023-03-30 | — | — | US | disclosed |
| US-11510890-B2 | Meroterpenoid compounds for use in the prevention and treatment of a neurological disorder | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2022-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11510890-B2 | Meroterpenoid compounds for use in the prevention and treatment of a neurological disorder | NLN, SLC6A13, SLC6A11 | FOLH1 1482/4885ALDH1A1 1446/4885ADRB2 1774/4885 |
| US-20230095374-A1 | MEROTERPENOID COMPOUNDS FOR USE IN THE PREVENTION AND TREATMENT OF A NEUROLOGICAL DISORDER | NLN, SLC6A13, SLC6A11 | FOLH1 1482/4885ALDH1A1 1446/4885ADRB2 1774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.